
January 2025: Notable Drug Approvals - The Cardiology Advisor
Feb 11, 2025 · The following are some of the notable drug approvals that occurred in January 2025. Omvoh (mirikizumab-mrkz) Humanized immunoglobulin G4 monoclonal antibody that selectively …
Childhood Cancer Treatments May Increase Diabetes Risk
Feb 25, 2025 · Childhood cancer treatments, specifically total body irradiation, were associated with increased risk of developing diabetes among cancer survivors.
Researchers Quantify the Risk for Diabetes After Gestational Diabetes
May 16, 2024 · Gestational diabetes is associated with an increased risk for subsequent diabetes, according to a study published online.
Combating Medical Mistrust in the Black Community
Nov 28, 2023 · Medical mistrust causes barriers to health promotion and prevention, leading to greater health disparities in minority communities.
Association of Black Cardiologists Launches Hypertension Management ...
Feb 12, 2024 · The Association of Black Cardiologists (ABC) is offering a Hypertension Control Program (HCP) certification for clinicians committed to preventing hypertension and improving hypertension …
Semaglutide Associated With Improved Symptoms in Obesity-Related …
Apr 26, 2024 · Semaglutide is associated with significant improvement in HF-related symptoms and reductions in body weight in patients with obesity-related HFpEF.
Postdischarge Suicide Prediction Improved With Social Determinants of ...
Feb 8, 2023 · Machine learning models that predict suicide following VHA psychiatric hospitalization can be improved with clinical notes and health public records.
Apixaban Compared With Dalteparin in Cancer-Related Venous ...
Jan 10, 2023 · Researchers determined oral apixaban and subcutaneous dalteparin showed similar rates of key outcomes for patients with cancer-related venous thromboembolism.
Venous Thromboembolism Linked to Hospitalization for an Eating …
May 25, 2023 · Researchers in Japan identified several characteristics that appeared linked to venous thromboembolism in patients hospitalized for an eating disorder.
Mavacamten and Septal Reduction Therapy in Patients With …
Aug 15, 2022 · Mavacamten reduces the need for septal reduction therapy at 16 weeks among symptomatic patients with obstructive hypertrophic cardiomyopathy.